Practice in Clinical and Molecular Thoracic European Pathology Laboratories During the COVID-19 Pandemic.

Centre Hospitalier Universitaire de Nice1 site in 1 country71 target enrollmentMarch 15, 2020

ConditionsClinical Practice During the COVID-19 Crisis

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Clinical Practice During the COVID-19 Crisis
Sponsor: Centre Hospitalier Universitaire de Nice
Enrollment: 71
Locations: 1
Primary Endpoint: Activity
Status: Completed
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The infectivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), notably when handling human samples, remains poorly understood, as well as the impact of the COVID-19 pandemic in routine clinical and molecular pathology practice, and for personal working in pathology laboratories. This study evaluates the consequences of the COVID-19 crisis in clinical and molecular pathology laboratories in Europe mostly those orientated for diagnosis of thoracic diseases.

Registry

clinicaltrials.gov

Start Date

March 15, 2020

End Date

May 31, 2020

Last Updated

5 years ago

Study Type

Observational

Sex

All